Genetic determinants of arterial thrombosis (Q40582647)

21 September 2017

1 reference

title

Genetic determinants of arterial thrombosis (English)

1 reference

21 September 2017

Green F

1

1 reference

21 September 2017

Humphries S

series ordinal

2

1 reference

21 September 2017

publication date

1 September 1994

1 reference

Best Practice and Research: Clinical Haematology

21 September 2017

published in

1 reference

21 September 2017

volume

7

1 reference

21 September 2017

issue

3

1 reference

21 September 2017

page(s)

675-692

1 reference

Risk of stroke in male cigarette smokers

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

DNA polymorphisms at fibrinogen loci and plasma fibrinogen concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

The triglyceride issue: a view from Framingham

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Interaction of a liver-specific nuclear factor with the fibrinogen and alpha 1-antitrypsin promoters

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

The human beta fibrinogen promoter contains a hepatocyte nuclear factor 1-dependent interleukin-6-responsive element

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

The status of PAI-1 as a risk factor for arterial and thrombotic disease: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Fibrinogen genotype and risk of peripheral atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Control of plasma fibrinogen levels

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Genetic and cultural inheritance of plasma fibrinogen concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Defective fibrinolysis in survivors of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase response

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Fibrinogen and risk of cardiovascular disease. The Framingham Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Genetic and environmental determinants of factor VII coagulant activity in ethnic groups at differing risk of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Population-based distributions of haemostatic variables

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

An epidemiological study of the haemostatic and other effects of oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Assay of factor VII activity by two techniques: evidence for increased conversion of VII to alpha VIIa in hyperlipidaemia, with possible implications for ischaemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Association between dietary fat intake and plasma factor VII coagulant activity--a predictor of cardiovascular mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Fat consumption and factor VII coagulant activity in middle-aged men. An association between a dietary and thrombogenic coronary risk factor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Turnover of factor X and of prothrombin in rabbits fed on a standard or cholesterol-supplemented diet

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

The prothrombin activation peptide regulates synthesis of the vitamin K-dependent proteins in the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Increased factor VII coagulant activity in the rabbit following diet-induced hypercholesterolaemia. Evidence for increased conversion of VII to alpha VIIa and higher flux within the coagulation pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Factor VII coagulant activity is strongly associated with the plasma concentration of large lipoprotein particles in middle-aged men.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Lipolysis of triglyceride-rich lipoproteins activates coagulant factor XII: a study in familial lipoprotein-lipase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Plasminogen activator inhibitor in the blood of patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Clotting factors VII and X as useful markers of terminal deletion of chromosome 13

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Minimal genetic influences on plasma fibrinogen level in adult males in the NHLBI twin study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

The regulatory region of the human plasminogen activator inhibitor type-1 (PAI-1) gene

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM Study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Hypertriglyceridaemia and hypercoagulability

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Linkage disequilibrium across the fibrinogen locus as shown by five genetic polymorphisms, G/A-455 (HaeIII), C/T-148 (HindIII/AluI), T/G+1689 (AvaII), and BclI (beta-fibrinogen) and TaqI (alpha-fibrinogen), and their detection by PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

Fibrinogen as a risk factor for stroke and myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980103-9

7 January 2021

10.1016/S0950-3536(05)80103-9

Identifiers

DOI

1 reference

21 September 2017

1 reference